Snapshot · Thermo Fisher Scientific Inc. (TMO)

Data as of 2026-09-02T00:05:51.263Z

Fundamentals check

Market cap

$223.2B

P/E (TTM)

32.3

Gross margin

40.4%

Net margin

15.1%

ROE

13.4%

R&D / revenue

3.0%

Dividend yield

0.3%

FCF yield

3.3%

Latest dividend: $0.47/share (ex-date 2026-09-15, quarterly)

Summary

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

How it makes money

Revenue mix, latest fiscal year

• Consumables41.9%
• Service41.7%
• Instruments16.4%

Recent Events

• 2026-08-28T10:03:28.000Znegative

  Ausdal Financial Partners Inc. Makes New $456,000 Investment in Thermo Fisher Scientific Inc. $TMO

  小额新进持股可能与股价短期回落相关，但不排除其他因素，因果关系尚不确定。

  Source: defenseworld.net

• 2026-08-21T04:51:28.000Zneutral

  Bank of New York Mellon Corp Invests $1.97 Billion in Thermo Fisher Scientific Inc. $TMO

  机构增持可能与股价小幅波动相关，但因果关系存在不确定性，需观察后续资金动向。

  Source: defenseworld.net

• 2026-08-19T04:29:36.000Zpositive

  BlackRock Inc. Takes $15.50 Billion Position in Thermo Fisher Scientific Inc. $TMO

  BlackRock 的大规模增持可能与股价上行相关，但无法确定因果关系，需关注后续交易情况。

  Source: defenseworld.net

• 2026-08-19T00:00:00.000Zpositive

  Price move: TMO rose 4.2%

  TMO 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-07-23T00:00:00.000Zpositive

  Price move: TMO rose 8.7%

  TMO 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-06-24T00:00:00.000Zpositive

  Price move: TMO rose 4.9%

  TMO 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-06-09T00:00:00.000Zpositive

  Price move: TMO rose 5.2%

  TMO 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

Analyst view

Avg price target $583.33 from 9 analysts (last quarter)

Insider & Congress activity

Open-market trades only; grants and exercises excluded

• 2026-08-31SellPettiti Gianluca(officer: President & COO)3,733 shares
• 2026-08-24SellCASPER MARC N(director, officer: Chairman & CEO)62 shares
• 2026-08-24SellCASPER MARC N(director, officer: Chairman & CEO)79 shares
• 2026-08-24SellCASPER MARC N(director, officer: Chairman & CEO)33 shares
• 2026-08-24SellCASPER MARC N(director, officer: Chairman & CEO)101 shares

US Congress trading disclosures

• 2026-03-27Alan ArmstrongPurchase$1,001 - $15,000

订阅每日简报

每个交易日开盘/收盘后，中文市场简报直达邮箱。免费，随时退订。

本内容仅为信息整理，不构成任何投资建议。